SEC FORM 4
$270,442.88
UNITED THERAPEUTICS Corp (UTHR)
Sale of 542 shares at $498.9721 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001106578-26-000134 · filed 2026-09-03 · View filing →